Ketamine and Psychedelic Therapy Near Me in the Inland Empire

How to Find Ketamine Care and a Psychedelic Therapist in the Inland Empire

If you are searching for ketamine treatment near you, there are two realistic paths in the Inland Empire. You can visit an in-clinic provider for IV or intramuscular (IM) ketamine, several of which operate across Riverside and San Bernardino counties, or you can complete a clinician-guided program at home through telehealth. Getting started is the same in spirit either way: ketamine is a prescription treatment, so the first step is an online clinical evaluation, and a licensed clinician decides whether it is a good fit for you.

Searching for a 'psychedelic therapist' or 'psychedelic therapists near me' surfaces a harder truth. Most of the psychedelic compounds people have in mind, psilocybin, MDMA, and LSD, are not legally available for therapy in California, so a true psychedelic therapist offering those is not something you will find operating openly in the Inland Empire. Ketamine is the exception, and it is why at-home ketamine therapy has become the practical starting point. Eligibility begins with an online clinician evaluation, and if approved you complete your at-home ketamine therapy in California program with Mindbloom from Riverside, Ontario, Fontana, or anywhere in the Inland Empire, with guidance throughout.

Ketamine and Psychedelic Therapy Availability Across the Inland Empire

Because Mindbloom is delivered at home over telehealth, its ketamine therapy reaches eligible adults across the whole Inland Empire, not only the cities that happen to have a clinic. That includes Riverside, San Bernardino, Ontario, Rancho Cucamonga, Fontana, Moreno Valley, Corona, and Redlands, along with the Temecula and Murrieta area to the southwest and the High Desert and Coachella Valley communities. You do not need to live near a physical location to begin. For people who prefer an in-person setting, in-clinic providers are concentrated in the region's larger cities: an infusion-focused ketamine clinic operates in Redlands¹⁴, and an interventional-psychiatry practice offering ketamine, Spravato, and TMS operates in Riverside and Eastvale.¹⁵ Access can still be a barrier locally: Riverside County has roughly one mental-health provider for every 353 residents, which is part of why at-home care with Mindbloom has become a practical option across these Inland Empire communities.¹¹

Your Ketamine and Psychedelic Therapy Options in the Inland Empire

Here is how the realistic options compare for someone in the Inland Empire weighing where to start.

The practical difference is access. In-clinic IV or IM ketamine means booking a series of in-person infusions, usually six over two to three weeks, and paying out of pocket. Spravato (esketamine) is FDA-approved for treatment-resistant depression and may be covered by insurance for people who qualify, subject to the insurer's prior authorization, otherwise it is out of pocket.¹³ Psilocybin therapy is often what people picture when they search for psychedelic therapy, but it is not legally available in California, and neither is MDMA-assisted therapy, which is not FDA-approved. That is the core reason ketamine, delivered at home by Mindbloom for eligible adults, is the psychedelic-class therapy most Inland Empire residents can actually begin now. If you are weighing formats, you can compare sublingual and IV ketamine directly.

Conditions Ketamine Therapy Can Address

Depression is the condition ketamine therapy is best known for, and it is the primary indication these at-home programs are built around. Ketamine therapy can also help with anxiety, PTSD, grief, burnout, and sleep difficulties. For the Inland Empire's large veteran community, PTSD is worth calling out: Mindbloom is the only at-home ketamine therapy provider with peer-reviewed PTSD outcomes¹, reporting a 76.7% PTSD response rate in its subcutaneous study. Coverage here stays within the conditions the evidence supports: depression, anxiety, PTSD, grief, burnout, and sleep.

Mindbloom's Psychedelic Therapy Programs and Outcomes

Mindbloom has delivered more than 800,000 guided at-home sessions and is one of the largest at-home psychedelic-therapy providers. Its outcomes draw on a peer-reviewed study of its subcutaneous protocol covering depression, anxiety, and PTSD in one study (Parks 2026)¹, alongside two earlier peer-reviewed studies of its sublingual protocol (Hull 2022 and Mathai 2024) and research preprints extending the evidence to grief, burnout, and sleep. Individual results vary.

_{Footnotes: ¹ Subcutaneous, six-session course (Parks 2026). Response = at least 50% reduction (PHQ-9/GAD-7) or 10-point reduction (PCL-5); remission = final PHQ-9/GAD-7 under 5, or a 10-point reduction and PCL-5 under 33. ² Grief (PGD-13), n=503. ³ Burnout (MBI-GS), n=395. ⁴ Sleep (PHQ-9 Item 3), n=13,963; single-item measure, ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1%). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0).}

These are tailored programs, built with mental-health thought leaders, that use the psychedelic modality to address specific outcomes rather than only prescribing medication for them. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

• Mindbloom's reported depression response rate is roughly 38% higher than the rate reported in a study of psychotherapy for depression (56.6% vs ~41%), and reached faster.¹ ⁵
• Mindbloom's reported anxiety response is comparable to the rate reported in a study of first-line SSRIs, without a daily pill.¹ ⁶
• Mindbloom's reported at-home PTSD response rate exceeds the rate reported in the leading repeated-infusion IV ketamine trial (76.7% vs 67%).¹ ⁷
• Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37 to 42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ⁸

Is Ketamine or Psychedelic Therapy Legal in California?

For ketamine, yes. Ketamine is legal, FDA-classified as Schedule III, and prescribable, including via telehealth, in California and every US state. That is why eligible adults can begin at-home ketamine therapy now. Psilocybin and MDMA are a different story: both remain Schedule I in California, and the state has no licensed psychedelic-therapy program.¹⁰ A 2024 bill (SB 1012) that would have created a regulated framework failed, and a small number of California cities have deprioritized enforcement of psilocybin, but none of them are in the Inland Empire, so no local exception applies here.¹⁰ In practical terms, ketamine is the psychedelic-class therapy you can legally start in the Inland Empire today.

How At-Home Ketamine Therapy Works

Ketamine works differently from daily antidepressants. It acts on the brain's glutamate system to support neuroplasticity, which is associated with rapid initial relief for some people and with cumulative benefit built over a course of sessions. A program is a series of guided sessions with preparation and integration around them, not a single dose. Every Mindbloom client starts with an online clinical evaluation, and a licensed clinician confirms eligibility and prescribes only when it is appropriate. Sessions are self-administered at home with guidance and monitoring, and treatment frequency is personalized under clinician guidance rather than fixed. It is intended for eligible adults, and screening for relevant medical and psychiatric history is part of determining fit.

Cost and Insurance

Mindbloom's at-home ketamine therapy is $165 to $215 per session depending on the program, billed as part of a multi-session package, and is HSA and FSA eligible, with possible out-of-network reimbursement. For comparison, in-clinic IV ketamine in the Inland Empire generally runs about $400 to $800+ per infusion, and a standard course of six infusions can total several thousand dollars.¹² Ketamine is not typically covered by insurance in either setting. Spravato is the exception that may be covered with prior authorization for people who qualify.¹³

Working With Your Existing Care Team

Ketamine therapy works best alongside ongoing mental-health care. If you already see a therapist or prescriber in the Inland Empire, at-home treatment can run in parallel with that support, and the integration work between sessions is where much of the lasting benefit tends to come from. If you want to find out whether it is a fit, eligibility begins with an online clinician evaluation.